FDA meeting to consider RSV vaccine for pregnant people

(NEW YORK) -- An advisory committee for the U.S. Food and Drug Administration is expected to meet Thursday to discuss drugmaker Pfizer's application for a new RSV vaccine for pregnant people, two weeks after the federal agency approved the first RSV vaccine for older... Read More.

First RSV vaccine could be approved this summer

(NEW YORK) -- After decades of research, a first-of-its kind vaccine designed to protect newborns against RSV, or respiratory syncytial virus, could be approved by August.Pfizer, the maker of the vaccine, announced Tuesday that the U.S. Food and Drug Administration has accepted its application... Read More.